1. Efficacy of emicizumab prophylaxis versus factor VIII prophylaxis for treatment of hemophilia A without inhibitors: network meta-analysis and sub-group analyses of the intra-patient comparison of the HAVEN 3 trial. (2nd December 2019) Authors: Reyes, Adriana; Révil, Cédric; Niggli, Markus; Chebon, Sammy; Schlagmüller, Simone; Flacke, Jan-Paul; Zortel, Max; Paz-Priel, Ido; Asikanius, Elina; Hampton, Roger; Mahajan, Anadi; Schmidt, Elvira; Edwards, Susan C. Journal: Current medical research and opinion Issue: Volume 35:Number 12(2019) Page Start: 2079 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Reply: RE: Reyes A, Révil C, Niggli M, et al. Efficacy of emicizumab prophylaxis versus factor VIII prophylaxis for treatment of hemophilia A without inhibitors: network meta-analysis and sub-group analyses of the intra-patient comparison of the HAVEN 3 trial. Curr Med Res Opin. 2019;35(12):2079–2087. (2nd July 2020) Authors: Reyes, Adriana; Révil, Cédric; Niggli, Markus; Chebon, Sammy; Schlagmüller, Simone; Flacke, Jan-Paul; Zortel, Max; Paz-Priel, Ido; Asikanius, Elina; Hampton, Roger; Mahajan, Anadi; Schmidt, Elvira; Edwards, Susan C. Journal: Current medical research and opinion Issue: Volume 36:Number 7(2020) Page Start: 1129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗